Company No: 16045503 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

	Note	31.12.2025
		£
Fixed assets
Investments	3	195,573
		195,573
Current assets
Debtors
- due within one year	4	11,790
- due after more than one year	4	250,000
Cash at bank and in hand		175,313
		437,103
Creditors: amounts falling due within one year	5	( 603,615)
Net current liabilities		(166,512)
Total assets less current liabilities		29,061
Net assets		29,061
Capital and reserves
Called-up share capital	6	100
Profit and loss account		28,961
Total shareholders' funds		29,061

For the financial period ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
• The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of AKX Enterprises Ltd (registered number: 16045503) were approved and authorised for issue by the Director on 04 June 2026. They were signed on its behalf by:

Dr S Ahmadzadeh Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

AKX Enterprises Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 60 Tottenham Court Road, Suite 5225a, Fitzrovia, London, W1T 2EW, United Kingdom.

The financial statements have been prepared under the historical cost convention, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover represents income from the company’s investments. Interest income is recognised using the effective interest method. Dividends and fund distributions are recognised when the company becomes entitled to receive them. Realised and unrealised gains or losses on investments measured at fair value through profit or loss are recognised in turnover in the period in which they arise.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including other creditors and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

2. Employees

	Period from 28.10.2024 to 31.12.2025
	Number
Monthly average number of persons employed by the Company during the period, including the director	1

3. Fixed asset investments

	Other investments		Total
	£		£
Cost or valuation before impairment
At 28 October 2024	0		0
Additions	195,573		195,573
At 31 December 2025	195,573		195,573
Carrying value at 31 December 2025	195,573		195,573

4. Debtors

	31.12.2025
	£
Debtors: amounts falling due within one year
Other debtors	11,790
Debtors: amounts falling due after more than one year
Other debtors	250,000

5. Creditors: amounts falling due within one year

	31.12.2025
	£
Amounts owed to Parent undertakings	601,300
Amounts owed to director	65
Accruals	2,250
	603,615

At the period end the company owed £65 to Dr S Ahmadzadeh. This amount is interest free, repayable on demand and is shown within other creditors.

6. Called-up share capital

	31.12.2025
	£
Allotted, called-up and fully-paid
1,000,000 Ordinary shares of £ 0.0001 each	100

7. Ultimate controlling party

Parent Company:

AKX Group Ltd

167-169 Great Portland Street, London, England, W1W 5PF